manA Resolved · high auto-curated

H37Rv Rv3255c · MTBC0 mtbc0_003463 · 408 aa · 3657184–3658410 MTBC0 (-) · RefSeq NP_217772.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)mannose-6-phosphate isomerase
MTBC0 PGAP re-annotationmannose-6-phosphate isomerase%2C class I
Revised (this work)Mannose-6-phosphate isomerase%2C class I. Pfam: PMI_typeI_cat (PF20511.5).
Functional category (TubercuList)intermediary metabolism and respiration

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 3 publications

3 TB publications mention this gene. 3 publications discuss this gene (count verified against title and abstract text). Queried separately, 4 records carry a M. tuberculosis context and none a non-TB mycobacterial context. The three counts come from three distinct PubMed queries (the total is text-verified, the context counts are raw query volumes), so they neither partition the total nor need to add up to it.

PublicationDate
Miliary tuberculosis in an immune-competent Bangladeshi man-A case report. doi:10.1002/ccr3.7516 2023
Mycobacterium ulcerans infection (Buruli ulcer) in French Guiana, South America, 1969-2013: an epidemiological study. doi:10.1016/S2542-5196(17)30009-8 2017
Comparative transcriptional study of the putative mannose donor biosynthesis genes in virulent Mycobacterium tuberculosis and attenuated Mycobacterium bovis BCG strains. doi:10.1128/IAI.05635-11 2011
Prevalence of sputum-positive pulmonary tuberculosis in tribal and non-tribal populations of the Ashti and Karanja tahsils in Wardha district, Maharashtra State, India. 1999
39 records returned by the alias sweep

Searched as: Rv3255c, manA, Mb3283c, ML0765, MMAR_1287, MSMEG_1836, MAB_3601c — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

This count disagrees with the 3 reported above. The two come from different methods and both are shown rather than one being silently overwritten. The figure above comes from the older curated source, which missed this gene; the sweep below queries every alias of the gene in a mycobacterial context. Where they differ this way, the list below is the one you can check line by line.

PublicationJournalYear
Adolescent health across Asia Pacific, 2000-23: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S2352-4642(26)00163-X Lancet Child Adolesc Health 2026
Global, regional, and national burden of HIV/AIDS, 1990-2023, with the estimated burden attributable to intimate partner violence and forecasted impacts of funding cuts through 2030: results from the Global Burden of Disease Study 2023. doi:10.1016/S2352-3018(26)00147-5 Lancet HIV 2026
Measuring the composition and availability of human resources for health by sex in 204 countries and territories, 1990-2023, and workforce gaps for universal health coverage: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S2468-2667(26)00145-3 Lancet Public Health 2026
Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023. doi:10.1001/jama.2026.8628 JAMA 2026
Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S1473-3099(26)00295-1 Lancet Infect Dis 2026
Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S1473-3099(26)00194-5 Lancet Infect Dis 2026
Updated trends in the global prevalence and burden of mental disorders, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S0140-6736(26)00519-2 Lancet 2026
Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S1474-4422(26)00101-8 Lancet Neurol 2026
Global burden of adverse effects of medical treatment from 1990 to 2021: a Global Burden of Disease Study 2021. doi:10.3904/kjim.2025.278 Korean J Intern Med 2026
Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S1470-2045(25)00730-2 Lancet Oncol 2026
Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S1473-3099(25)00689-9 Lancet Infect Dis 2026
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S0140-6736(25)01917-8 Lancet 2025
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S0140-6736(25)01330-3 Lancet 2025
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S0140-6736(25)01637-X Lancet 2025
The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S0140-6736(25)01635-6 Lancet 2025
Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023. doi:10.1016/j.jacc.2025.08.015 J Am Coll Cardiol 2025
Deciphering the emerging role of phytocompounds: Implications in the management of drug-resistant tuberculosis and ATDs-induced hepatic damage. doi:10.1016/j.jiph.2023.07.016 J Infect Public Health 2023
Miliary tuberculosis in an immune-competent Bangladeshi man-A case report. doi:10.1002/ccr3.7516 Clin Case Rep 2023
An Attention towards the Prophylactic and Therapeutic Options of Phytochemicals for SARS-CoV-2: A Molecular Insight. doi:10.3390/molecules28020795 Molecules 2023
MmpL3 Inhibition as a Promising Approach to Develop Novel Therapies against Tuberculosis: A Spotlight on SQ109, Clinical Studies, and Patents Literature. doi:10.3390/biomedicines10112793 Biomedicines 2022
Pharmacological Efficacy of Tamarix aphylla: A Comprehensive Review. doi:10.3390/plants11010118 Plants (Basel) 2021
Glycyrrhiza glabra (Licorice): A Comprehensive Review on Its Phytochemistry, Biological Activities, Clinical Evidence and Toxicology. doi:10.3390/plants10122751 Plants (Basel) 2021
The possible impact of socioeconomic, income, and educational status on adverse effects of drug and their therapeutic episodes in patients targeted with a combination of tuberculosis interventions. doi:10.1016/j.sjbs.2021.02.004 Saudi J Biol Sci 2021
Oral tuberculosis in a patient with Crohn's disease on TNF-α blockers. doi:10.1111/jdv.16961 J Eur Acad Dermatol Venereol 2021
Determination of isoniazid acetylation patterns in tuberculosis patients receiving DOT therapy under the Revised National tuberculosis Control Program (RNTCP) in India. doi:10.1016/j.jsps.2020.04.003 Saudi Pharm J 2020
Adverse drug reaction prevalence and mechanisms of action of first-line anti-tubercular drugs. doi:10.1016/j.jsps.2020.01.011 Saudi Pharm J 2020
Functional Replacement of Histidine in Proteins To Generate Noncanonical Amino Acid Dependent Organisms. doi:10.1021/jacs.7b13452 J Am Chem Soc 2018
Mycobacterium ulcerans infection (Buruli ulcer) in French Guiana, South America, 1969-2013: an epidemiological study. doi:10.1016/S2542-5196(17)30009-8 Lancet Planet Health 2017
Discriminating unalike single nucleobase mismatches using a molecularly resolved, label-free, interfacial LNA-based assay. doi:10.1039/c6an00484a Analyst 2016
Rapid detection of coliforms in drinking water of Arak city using multiplex PCR method in comparison with the standard method of culture (Most Probably Number). doi:10.12980/APJTB.4.2014C896 Asian Pac J Trop Biomed 2014
Coinfection with Mycobacterium tuberculosis and Pneumocystis Jirovecii in immunocompetent young woman. Arch Inst Pasteur Tunis 2013
Feasibility and efficacy of isoniazid prophylaxis for latent tuberculosis in HIV-infected clients patients in Thailand. doi:10.1089/aid.2011.0041 AIDS Res Hum Retroviruses 2012
Comparative transcriptional study of the putative mannose donor biosynthesis genes in virulent Mycobacterium tuberculosis and attenuated Mycobacterium bovis BCG strains. doi:10.1128/IAI.05635-11 Infect Immun 2011
Absence of ribosomal RNA of Mycobacterium tuberculosis complex in sarcoidosis. doi:10.1001/archderm.141.1.57 Arch Dermatol 2005
Epidemiological considerations about retinal opportunistic infections in HIV-infected patients in France. doi:10.1076/ocii.7.3.167.3997 Ocul Immunol Inflamm 1999
Prevalence of sputum-positive pulmonary tuberculosis in tribal and non-tribal populations of the Ashti and Karanja tahsils in Wardha district, Maharashtra State, India. Int J Tuberc Lung Dis 1999
Sarcoidosis: chest radiograph screening of familial contacts. doi:10.1159/000196537 Respiration 1996
[Radiology of pulmonary tuberculosis in diabetic patients]. Med Clin (Barc) 1983
[Mitral stenosis with pulmonary hemosiderosis complicated by terminal tuberculous meningitis; contribution to the diagnosis and pathogenesis of miliary opacities in the lungs]. Tuberkuloza 1953

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Genomic-neighbour overlap (structural caveat) antiparallel · 2 % of gene

NeighbourRv3254 (Rv3254, + strand)
Overlap23 bp, 2 % of this gene's length

antiparallel overlap: this gene may inherit essentiality/conservation signal from its neighbour through shared TA sites or promoter constraint, without any protein of its own being produced (cf. Rv2438A/nadE) Signals attributed to this gene (Tn-seq essentiality via shared TA sites, conservation via promoter constraint) should be cross-checked against the neighbour before being read as its own. P20.1, derived from GFF3 gene coordinates, 2026-08-03.

CRISPRi vulnerability

Vulnerability index -6.48 (95% CI -6.70 to -6.27). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Legacy record & comparison (Mycobrowser)

Mycobrowser functionThis enzyme converts D-mannose 6-phosphate to D-fructose 6-phosphate [catalytic activity: D-mannose 6-phosphate = D-fructose 6-phosphate].
Mycobrowser EC 5.3.1.8 · agrees with the atlas

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb3283c · 99.8% identity
M. leprae ML0765 · 82.7% identity
M. marinum MMAR_1287 · 87.7% identity
M. smegmatis MSMEG_1836 · 76.5% identity
M. orygis RJtmp_003355 · 99.8% identity
M. abscessus MAB_3601c · 63.3% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt O05898 TrEMBL · unreviewed · Evidence at protein level
UniProt namemannose-6-phosphate isomerase
EC (curated) EC 5.3.1.8

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category G Carbohydrate transport and metabolism
Preferred namemanA
eggNOG descriptionmannose-6-phosphate isomerase
Orthologous groupCOG1482
EC number EC 5.3.1.8
KEGG orthology K01809
KEGG pathways map00051, map00520, map01100, map01110, map01130
KEGG modules M00114

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.243 · quasi-invariant (5 sites), pN/pS underpowered
Polymorphic sites (≥ 0.1% of strains) 3 synonymous, 2 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Bacteria

Genus-wide presence (~53 non-MTBC Mycobacterium) present in 53/53 (100%) · mean identity 84.4% · 4/4 closest MTBAP relatives
conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 11/13 non-Mycobacterium reference genomes (down to Bacteria) · mean identity 50.2%
detected down to outside the phylum (Proteobacteria/Firmicutes controls) — a universally conserved, ancient bacterial gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis) essential

DeJesus 2017 callES · essential
What the call meansessential: insertions absent across the whole ORF
TA sites (Himar1) 21 in the ORF — 21 in the essential state, 0 growth-defect, 0 non-essential, 0 growth-advantage. Saturation 0.000, mean read count 0. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 21 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Chemical-genetic target & druggability (PROSPECT) hypomorph tool strain

This gene is part of the PROSPECT collection of TetON transcriptional-knockdown (hypomorph) strains of essential M. tuberculosis genes, built as a sensitised background for chemical-genetic mechanism-of-action deconvolution. Being in the panel means the gene is an essential / vulnerable target for which a validated knockdown tool strain exists.

Hypomorph strainRv3255c (manA)_flag/DAS +pTetON-18_sspB (TetON promoter 18)
Baseline knockdown fitness4.572 median doublings (across 6 screen pool(s)) — fewer doublings = stronger growth defect on knockdown
Used in target deconvolutionyes (informs phenotypic-cluster / MOA assignment)

Panel membership reflects essentiality/vulnerability and the availability of a genetic tool, not a specific molecular function; it never changes the verdict here. Source: Bond AN et al., Nat Commun 2025;16:9673 (doi:10.1038/s41467-025-64662-x); PROSPECT chemical-genetic platform.

Mutant phenotypes (conditional Tn-seq, MtbTnDB)

Conditionlog2FCqEffect
Differential genetic requirements of clinical Mtb strain (ID=621) from East Asian lineage (compared to H37Rv control) (strain background) +6.370.0 required
Differential genetic requirements of clinical Mtb strain (ID=662) from East Asian lineage (compared to H37Rv control) (strain background) +6.150.0 required
Differential genetic requirements of clinical Mtb strain (ID=631) from East Asian lineage (compared to H37Rv control) (strain background) +5.880.0 required
Differential genetic requirements of clinical Mtb strain (ID=632) from East Asian lineage (compared to H37Rv control) (strain background) +5.710.0 required
Differential genetic requirements of clinical Mtb strain (ID=667) from Indo-Oceanic lineage (compared to H37Rv control) (strain background) +5.710.0 required
Differential genetic requirements of clinical Mtb strain (ID=641) from Indo-Oceanic lineage (compared to H37Rv control) (strain background) +5.090.0 required
Differential genetic requirements of clinical Mtb strain (ID=663) from Euro-American lineage (compared to H37Rv control) (strain background) +1.460.0075 required

Conditional fitness of transposon-disruption mutants across 7 significant condition(s) (|log2FC|≥1, q≤0.05), from the standardized MtbTnDB compendium. A negative log2FC means the mutant is depleted — the gene contributes to fitness in that condition. An in-vivo defect for a "hypothetical" is strong evidence it matters for infection, even without a known molecular function. Disruption (Tn insertion), not a clean deletion; genetic-interaction screens excluded.

Proteomics (mass spectrometry) detected

MS detectiondetected in 15 of 16 independent MS datasets
Integrated abundance343.0 ppm · rank 585/3519 (83.4th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length408 aa
Molecular weight43.4 kDa
Theoretical pI4.98
GRAVY0.025 (hydrophobic)
Aliphatic index98.8
Aromaticity0.064
Instability index35.2 (stable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
PMI_typeI_catPF20511.5 5.5e-254–150 Phosphomannose isomerase type I, catalytic domain

3D structure (interactive — Mol*/pdbe-molstar)

No experimental structure is deposited for this gene: showing the AlphaFold DB predicted model (mean pLDDT 96.5, very high), coloured by per-residue confidence (dark blue = very high, orange/red = low — treat low-confidence regions as unreliable, especially termini and loops). Drag to rotate, scroll to zoom.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 96.5

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
5zt5-assembly1_A 1.00 0.94 0.90 0.94 36% 100% / 100% 3.5e-42 sig 5zt5-assembly1_A Crystal structure of E134A mutant of phosphomannose isomerase from Salmonella typhimurium
5zvx-assembly1_A 1.00 0.94 0.90 0.94 36% 100% / 100% 5.1e-42 sig 5zvx-assembly1_A Crystal structure of K86A mutant of phosphomannose isomerase from Salmonella typhimurium
3h1w-assembly1_A 1.00 0.93 0.89 0.93 36% 100% / 100% 3.7e-42 sig 3h1w-assembly1_A Crystal structure of mannose 6-phosphate isomerase bound with zinc and yttrium
3h1m-assembly1_A 1.00 0.93 0.89 0.93 37% 100% / 99% 5.4e-42 sig 3h1m-assembly1_A Crystal structure of mannose 6-phosphate isomerase (holo; zinc bound)
5zt4-assembly1_A 1.00 0.93 0.90 0.93 36% 100% / 100% 1.5e-41 sig 5zt4-assembly1_A Crystal structure of H99A mutant of phosphomannose isomerase from Salmonella typhimurium

Foldseek search of the AlphaFold DB model (mean pLDDT 96.5, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon) operon of 3

Upstream (5' on genome)Rv3254 (+ strand, -23 bp gap)
Downstream (3' on genome)Rv3256c (- strand, 7 bp gap)
Predicted operon manA · Rv3256c · pmmA

Neighbours from the H37Rv annotation (- strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) no multi-gene operon predicted (singleton) — disagrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT3353) exponential phase: operon of 4, Rv3255c · Rv3256c · Rv3257c · Rv3258c (coverage 97.35)
stationary phase: operon of 3, Rv3255c · Rv3256c · Rv3257c (coverage 18.4) — agrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: pmmA (phosphomannomutase PmmA), high confidence (score 990, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence). The pair is recorded in a curated database (pathway or complex membership) for M. tuberculosis genes themselves (score ≥ 200): a curated association, not a measurement in this organism.

Showing the 15 strongest of this gene's 22 partners at medium confidence (9 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 22 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv3257c pmmA curated phosphomannomutase PmmA 994 990 ctx neighborhood:882 database:900 textmining:417
Rv3256c hypothetical protein 989 945 ctx neighborhood:881 coexpression:553 textmining:809
Rv0946c pgi curated glucose-6-phosphate isomerase 944 927 database:900
Rv2029c pfkB curated 6-phosphofructokinase PfkB 917 906 database:900
Rv3308 pmmB curated phosphomannomutase PmmB 982 905 database:900 textmining:822
Rv3436c glmS curated glucosamine--fructose-6-phosphate aminotransferase 957 904 database:900 textmining:574
Rv3010c pfkA curated 6-phosphofructokinase 916 903 database:900
Rv1099c glpX curated fructose 1,6-bisphosphatase 904 901 database:900
Rv3258c dark hypothetical protein 641 624 ctx neighborhood:618
Rv3259 hypothetical protein 554 554 ctx neighborhood:552
Rv1438 tpi triosephosphate isomerase 571 496
Rv2783c gpsI bifunctional guanosine pentaphosphate synthetase/polyribonucleotide nucleotidyltransferase 472 473 ctx fusion:465
Rv3335c yhjD integral membrane protein 420 420
Rv2852c mqo malate:quinone oxidoreductase 448 278
Rv0620 galK galactokinase 423 269

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: mannose-6-phosphate isomerase
  • MTBC0 PGAP product: mannose-6-phosphate isomerase%2C class I
  • Pfam (hmmscan --cut_ga): PMI_typeI_cat PF20511.5 (E=6e-25)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_217772.1)
  • Domains: Pfam-A via hmmscan --cut_ga — PMI_typeI_cat (PF20511.5)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG1482
  • Curated reference: UniProt O05898 (TrEMBL, unreviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 96.5)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 22 functional partner(s); context anchor pmmA
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Mutant phenotypes: standardized Tn-seq compendium MtbTnDB (Jinich et al. 2025, doi:10.1111/mmi.15370), aggregating many primary Tn-seq studies across conditions
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_003463|Rv3255c|manA
MELLRGALRTYAWGSRTAIAEFTGRPVPAAHPEAELWFGAHPGDPAWLQTPHGQTSLLEALVADPEGQLGSASRARFGDVLPFLVKVLAADEPLSLQAHPSAEQAVEGYLREERMGIPVSSPVRNYRDTSHKPELLVALQPFEALAGFREAARTTELLRALAVSDLDPFIDLLSEGSDADGLRALFTTWITAPQPDIDVLVPAVLDGAIQYVSSGATEFGAEAKTVLELGERYPGDAGVLAALLLNRISLAPGEAIFLPAGNLHAYVRGFGVEVMANSDNVLRGGLTPKHVDVPELLRVLDFAPTPKARLRPPIRREGLGLVFETPTDEFAATLLVLDGDHLGHEVDASSGHDGPQILLCTEGSATVHGKCGSLTLQRGTAAWVAADDGPIRLTAGQPAKLFRATVGL